Group 1 - The core viewpoint of the article highlights the successful IPO of Nanjing Weili Zhizhi Bio-Tech Co., Ltd. on the Hong Kong Stock Exchange, with a first-day opening increase of 106.86% and a closing price of 67.1 HKD per share, resulting in a total market capitalization of 13 billion HKD [1] - The company aims to raise approximately 189 million USD through this issuance, with cornerstone investors including Zhengxin Valley Capital, Gao Yi Investment, Tencent, and E Fund [1][3] - Weili Zhizhi is a clinical-stage biotech company founded in 2012, focusing on the discovery, development, and commercialization of innovative therapies, with its founders having experience in tumor immunotherapy research at the National Cancer Institute in the United States [3] Group 2 - The company has a diversified product portfolio consisting of 14 innovative drug candidates, including 4 core products, all of which are among the leading candidates in global clinical progress [4] - Despite the long R&D cycles and heavy upfront investments typical in the biopharmaceutical industry, Weili Zhizhi reported a revenue of 8.865 million CNY in 2023, with net losses of 362 million CNY, 301 million CNY, and 75.367 million CNY for the first three months of 2023, 2024, and 2025 respectively, alongside R&D expenditures of 231 million CNY, 186 million CNY, and 57.751 million CNY during the same periods [5] - The company experienced significant market interest prior to its IPO, with cumulative fundraising exceeding 1 billion CNY and a subscription multiple of 3029 times, amounting to nearly 340 billion CNY in subscription amounts [5]

Core Viewpoint - The article highlights the active cash dividend distribution by listed companies in the context of regulatory encouragement, with a total of 3,679 companies proposing distribution plans for the 2024 fiscal year, including cash dividends totaling 1.64 trillion yuan [1][2]. Group 1: Dividend Distribution - A total of 3,674 companies included cash dividends in their 2024 distribution plans, with a cumulative cash payout of 1.64 trillion yuan [1]. - There are 346 companies that included stock transfers in their distribution plans for 2024 [1]. - The article emphasizes two important dates for investors focused on dividends: the ex-dividend date and the record date, with 3,398 companies having already implemented their distribution plans [1]. Group 2: Companies with Dividend Plans - Among the 13 companies with record dates today, 9 companies have a cash dividend of 1 yuan (after tax) or more per 10 shares, with Weike Technology offering the highest at 6.00 yuan per 10 shares [1][2]. - The companies listed for dividend distribution include: - Weike Technology: 6.00 yuan per 10 shares, latest closing price 83.66 yuan, 5-day increase 30.35% [2]. - Zhejiang Medicine: 3.70 yuan per 10 shares, latest closing price 15.51 yuan, 5-day increase 1.31% [2]. - Hangzhou Bank: 2.80 yuan per 10 shares, latest closing price 16.85 yuan, 5-day decrease 2.94% [2].

证券代码：002040 证券简称：南京港 公告编号：2025－041 南京港股份有限公司 2024年年度权益分派实施公告 本公司及董事会全体成员保证公告内容真实、准确和完整，对公告的 虚假记载、误导性陈述或者重大遗漏负连带责任。 股票合计 1,961,280 股。截至 2025 年 7 月 14 日，公司已在中国证券登记 结算有限责任公司深圳分公司办理完成 1,961,280 股限制性股票的回购注 销手续，公司股份总数由 489,908,265 股变更为 487,946,985 股。 3. 公司本次实施的分配方案以固定总额的方式分配，与股东大会审 议通过的分配方案一致。 4. 本次实施分配方案距离股东大会审议通过的时间未超过两个月。 二、本次权益分派方案 本公司 2024 年年度权益分派方案为：以公司现有总股本剔除已回购 股份 0.00 股后的 487,946,985.00 股为基数，向全体股东每 10 股派 0.950000 元人民币现金（含税；扣税后，境外机构（含 QFII、RQFII）以及持有首 发前限售股的个人和证券投资基金每 10 股派 0.855000 元；持有首发后限 售股、股权激励限售股及无限 ...

证券简称：南京港 证券代码：002040 公告编号：2025-040 南京港股份有限公司 关于部分限制性股票回购注销完成的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，对公告的 虚假记载、误导性陈述或者重大遗漏负连带责任。 特别提示： 1. 公司本次回购注销部分激励对象已获授但尚未解除限售的限制性 股票合计1,961,280股，占回购前公司总股本的0.40%；首次授予部分限制 性股票回购价格为3.511元/股，预留授予部分限制性股票回购价格为3.328 元/股；回购金额为人民币6,858,274.68元，涉及人数57人。 2. 截至2025年7月14日，上述限制性股票已在中国证券登记结算有限 责任公司深圳分公司办理完成注销手续。 3. 本次回购注销完成后，公司股份总数由489,908,265股变更为 487,946,985股。 南京港股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开 的第八届董事会 2025 年第二次会议、第八届监事会 2025 年第二次会议， 以及于 2025 年 5 月 20 日召开的 2024 年度股东大会，审议通过了《关于 2022 年限制性股票激励计 ...

Group 1 - Nanjing Economic Development Zone has recently secured significant domestic and international project orders, showcasing "Nanjing Intelligent Manufacturing" through advanced technology and quality [1] - Kanni Electromechanical, a core supplier for global high-end railway manufacturer Stadler, has customized 11 modular products for a major project, ensuring a lifespan of 40 years and aiming to deliver 557 railway cars by 2030 in Kazakhstan [1] - The Guangzhou Metro Line 10 has officially opened, featuring the highest level of automation (GoA4), with China Railway Baogao Nanjing Company supplying key switch systems [2] Group 2 - China Construction Fifth Engineering Division has successfully completed the first batch of 8 giant wind power tower tubes for the ACWA Egypt wind power project, with a total installed capacity of 1100 MW, contributing to Egypt's energy transition [2] - The project team faced challenges such as tight schedules and complex logistics, implementing a dual-shift system to ensure high-quality delivery of over 20,000 tons of tower tubes [2] - Nanjing Port Machinery Heavy Industry has delivered a multi-purpose crane to a Vietnamese client, marking the third batch of equipment purchased, demonstrating trust in the company's technology and service [3]

证券代码：002040 证券简称：南京港 公告编号：2025－039 南京港股份有限公司 关于部分理财产品到期赎回及继续使用暂时闲置自有资金购买 保本型理财产品的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，对公告的 虚假记载、误导性陈述或者重大遗漏负连带责任。 南京港股份有限公司（以下简称"公司"或"本公司"）于2024年8 月27日召开的第八届董事会2024年第四次会议及2024年9月12日召开的 2024年第三次临时股东大会，审议通过了《关于用暂时闲置自有资金购买 保本型理财产品的议案》，同意公司在确保不影响正常生产经营、有 效控制风险的前提下，使用不超过人民币40,000万元（其中包括南京 港龙潭集装箱有限公司不超过10,000万元）闲置自有资金购买保本型 理财产品，单个理财产品的投资期限不超过12个月，在上述额度及决议有 效期内，资金可以滚动使用。具体情况详见公司于2024年8月28日和2024 年9月13日在《证券时报》及巨潮资讯网（http://www.cninfo.com.cn/）刊 登的《南京港股份有限公司第八届董事会2024年第四次会议决议公告》（公 告编号：2024-03 ...

Core Viewpoint - The legal opinion letter confirms that the procedures for the 2025 second extraordinary general meeting of Nanjing Port Co., Ltd. were conducted in compliance with relevant laws, regulations, and the company's articles of association [2][3][8]. Group 1: Meeting Procedures - The notice for the meeting included details on time, location, method of convening, convenor, agenda items, attendees, registration methods, and other relevant matters [3][4]. - The meeting adopted a combination of on-site and online voting methods, with the on-site meeting held in a conference room and presided over by Chairman Zhao Jianhua [4][6]. - The convening procedures for the meeting were verified to comply with legal and regulatory requirements [4][7]. Group 2: Attendance and Qualifications - A total of 329,168,637 shares were represented at the meeting, accounting for 67.1899% of the company's total share capital [4][6]. - Two shareholders and their proxies attended the on-site meeting, representing 327,604,671 shares [4][6]. - The qualifications of attendees and the convenor were confirmed to be valid and in accordance with legal requirements [6][7]. Group 3: Voting Procedures and Results - The voting process was conducted through a combination of on-site and online methods, with no voting on matters not listed in the meeting notice [7][8]. - The total number of valid voting shares represented at the meeting was 99.8017%, with 58.2595% of minority shareholders voting in favor of the proposals [7][8]. - The voting results were confirmed to be legal and valid, with the proposals passing [7][8].

Meeting Details - The shareholder meeting was held on June 25, 2025, with specific time slots for different sessions [2] - A total of 325 shareholders and representatives attended the meeting, representing 327,604,671 shares, which is 66.8706% of the total share capital [2] Voting Results - The meeting approved the election of Mr. Zhu Tongcai and Mr. Zhang Chuanping as directors of the eighth board [3] - Mr. Zhu Tongcai received 99.8017% approval from the voting shareholders, with 911,159 shares from small shareholders representing 58.2595% of their voting rights [3] - Mr. Zhang Chuanping received 99.8034% approval, with 916,877 shares from small shareholders representing 58.6251% of their voting rights [3] Legal Opinions - The legal opinion from Jiangsu Taihe Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations, and the voting results were valid [4]

江苏泰和律师事务所 关于南京港股份有限公司 2025 年第二次临时股东大会的 法律意见书 2016.01.16 签署版 法律意见书 江苏泰和律师事务所 关于南京港股份有限公司 2025 年第二次临时股东大会的 法律意见书 为出具本法律意见书，本所律师依据《律师事务所从事证券法律业务管理办 法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行了法定 职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事项进行 了必要的核查和验证，并全程参加了本次股东大会。 本所保证本法律意见书所认定的事实真实、准确、完整，所发表的结论性意 见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并愿意承担相应法 律责任。 本所律师按照律师行业公认的业务标准、道德规范和勤勉尽责的精神，对本 次股东大会进行见证，并对公司提供的本次股东大会的相关文件资料及本次股东 大会的召集与召开程序、出席会议人员资格、召集人的资格和股东大会的表决程 序、表决结果等事项进行了核查验证，现发表法律意见如下： 一、本次股东大会的召集和召开程序 - 1 - 法律意见书 2025 年 6 月 9 日，公司召开第八届董事会 2025 年第 ...

证券代码：002040 证券简称：南京港 公告编号：2025－038 南京港股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，并对公 告中的虚假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1. 本次股东大会未出现否决提案的情形。 2. 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1. 召开方式：现场表决与网络投票相结合的方式。 2. 现场会议召开时间：2025 年 6 月 25 日（周三）15:00 3. 现场会议召开地点：南京市鼓楼区公共路 19 号南京港口大厦 A 座 1922 会议室。 4. 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具 体时间为 2025 年 6 月 25 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通 过深圳证券交易所互联网投票系统投票时间为：2025 年 6 月 25 日 9:15 至 15:00 期间的任意时间。 5. 召集人：公司董事会 6. 主持人：董事长赵建华先生 经合并统计现场和网络投票表决结果，本次股东大会审议通过了 ...